BioSpace News Archive

Press Releases

Allarity Therapeutics announces that its collaborative Phase 2 trial with the United States Veteran’s Administration Combining Stenoparib with Temozolomide in Relapsed Small Cell Lung Cancer is Now Open for Enrollment

February 3, 2026
·
8 min read
Press Releases

Byonyks X1: Revolutinizing Dialysis - Now FDA Cleared and Planning to start Patients in the U.S.

February 3, 2026
·
3 min read
Press Releases

Ultragenyx Announces Positive Longer-Term Data Demonstrating Treatment with UX111 Gene Therapy Results in Sustained, Significant Reductions in CSF-HS and Continued Meaningful Improvements in Clinical Function Across Multiple Developmental Domains in Children with Sanfilippo Syndrome (MPS IIIA)

February 3, 2026
·
10 min read
Press Releases

Replimune Reports Fiscal Third Quarter 2026 Financial Results and Provides Corporate Update

February 3, 2026
·
10 min read
Press Releases

Kyverna Therapeutics Appoints Mayo Pujols as Chief Technology Officer

February 3, 2026
·
6 min read
Press Releases

Enovis to Participate in the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference

February 3, 2026
·
1 min read
Press Releases

aTyr Pharma Announces Scheduling of FDA Type C Meeting to Discuss Efzofitimod Program in Pulmonary Sarcoidosis

February 3, 2026
·
5 min read
Press Releases

Milestone Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - February 3, 2026

February 3, 2026
·
1 min read
Press Releases

IN8bio to Present at Upcoming Investor and Scientific Conferences in February 2026

February 3, 2026
·
1 min read
Press Releases

Amicus Therapeutics Presents New Long-term Data for both Galafold® (migalastat) and POMBILITI® (cipaglucosidase alfa-atga) + OPFOLDA® (miglustat) at the 22nd Annual WORLDSymposium™ 2026

February 3, 2026
·
10 min read